These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20355163)

  • 21. Do dried blood spots (DBS) have the potential to support result management processes in routine sports drug testing?
    Thevis M; Kuuranne T; Dib J; Thomas A; Geyer H
    Drug Test Anal; 2020 Jun; 12(6):704-710. PubMed ID: 32180361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sports drug testing: Analytical aspects of selected cases of suspected, purported, and proven urine manipulation.
    Thevis M; Geyer H; Sigmund G; Schänzer W
    J Pharm Biomed Anal; 2012 Jan; 57():26-32. PubMed ID: 21955645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New drugs and methods of doping and manipulation.
    Thevis M; Kohler M; Schänzer W
    Drug Discov Today; 2008 Jan; 13(1-2):59-66. PubMed ID: 18190865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and accreditation of anti-doping laboratories for the Olympic Games.
    Botrè F; Wu M; Boghosian T
    Bioanalysis; 2012 Jul; 4(13):1623-31. PubMed ID: 22831478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbon isotope ratio (delta13C) values of urinary steroids for doping control in sport.
    Cawley AT; Trout GJ; Kazlauskas R; Howe CJ; George AV
    Steroids; 2009 Mar; 74(3):379-92. PubMed ID: 19056414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. hGH isoform differential immunoassays applied to blood samples from athletes: decision limits for anti-doping testing.
    Hanley JA; Saarela O; Stephens DA; Thalabard JC
    Growth Horm IGF Res; 2014 Oct; 24(5):205-15. PubMed ID: 24973245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug testing data from the 2007 Pan American Games: delta13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS.
    Aguilera R; Chapman TE; Pereira H; Oliveira GC; Illanes RP; Fernandes TF; Azevedo DA; Neto FA
    J Steroid Biochem Mol Biol; 2009 Jul; 115(3-5):107-14. PubMed ID: 19428237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis.
    Badoud F; Grata E; Perrenoud L; Avois L; Saugy M; Rudaz S; Veuthey JL
    J Chromatogr A; 2009 May; 1216(20):4423-33. PubMed ID: 19342059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2014; 6(1-2):164-84. PubMed ID: 24285613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarker monitoring in sports doping control.
    Pottgiesser T; Schumacher YO
    Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N,N-dimethyl-2-phenylpropan-1-amine - new designer agent found in athlete urine and nutritional supplement.
    Kwiatkowska D; Wójtowicz M; Jarek A; Goebel C; Chajewska K; Turek-Lepa E; Pokrywka A; Kazlauskas R
    Drug Test Anal; 2015 Apr; 7(4):331-5. PubMed ID: 25355281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doping droops.
    Chaturvedi A; Chaturvedi H; Kalra J; Kalra S
    Indian J Physiol Pharmacol; 2007; 51(2):118-30. PubMed ID: 18175655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stabilization of human urine doping control samples: II. microbial degradation of steroids.
    Tsivou M; Livadara D; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG
    Anal Biochem; 2009 May; 388(1):146-54. PubMed ID: 19232313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2011 lAAF World Championships in Daegu: blood tests for all athletes in the framework of the Athlete Biological Passport.
    Robinson N; Dollé G; Garnier PY; Saugy M
    Bioanalysis; 2012 Jul; 4(13):1633-43. PubMed ID: 22831479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detecting doping use: more than an analytical problem.
    Delanghe JR; Maenhout TM; Speeckaert MM; De Buyzere ML
    Acta Clin Belg; 2014; 69(1):25-9. PubMed ID: 24635395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlling sources of preanalytical variability in doping samples: challenges and solutions.
    Lippi G; Mattiuzzi C; Banfi G
    Bioanalysis; 2013 Jun; 5(12):1571-82. PubMed ID: 23795934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection methods for autologous blood doping.
    Segura J; Monfort N; Ventura R
    Drug Test Anal; 2012 Nov; 4(11):876-81. PubMed ID: 22407819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Veterinary medicines and competition animals: the question of medication versus doping control.
    Toutain PL
    Handb Exp Pharmacol; 2010; (199):315-39. PubMed ID: 20204593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2013 Jan; 5(1):1-19. PubMed ID: 23229872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement uncertainty in anti-doping quantitative analysis for prohibited threshold substances.
    Barroso O; Miller J; Squirrell A; Westwood S
    Bioanalysis; 2012 Jul; 4(13):1653-65. PubMed ID: 22831481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.